Case number 1:22-cv-01291
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 18, 2022 | 18 | SO ORDERED re (23 in 1:22-cv-00439-MN, 17 in 1:22-cv-01291-MN) Stipulation and Order Regarding Case Consolidation. Signed by Judge Maryellen Noreika on 11/18/2022. (dlw) (Entered: 11/18/2022) (3) |
| Nov 17, 2022 | 17 | STIPULATION Regarding Consolidation, Case Schedule, and Protective Order, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/17/2022) (3) |
| Nov 10, 2022 | 15 | REDACTED VERSION of 13 Stipulation of Dismissal by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 11/10/2022) (5) |
| Nov 10, 2022 | 16 | STIPULATION Seeking to Extend the Deadline by Which the Parties in the Non-Consolidated Cases Must Inform the Court Whether they Agree to be Consolidated With, and Adopt the Schedule of the Lead Case, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/10/2022) (5) |
| Nov 3, 2022 | 13 | [SEALED] STIPULATION of Dismissal Without Prejudice (Zydus Healthcare (USA) LLC) and Order Amending Caption by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 11/3/2022 (dlw). (Entered: 11/03/2022) (0) |
| Nov 3, 2022 | 14 | [SEALED] SO ORDERED re 13 Stipulation and Order Dismissing Defendant Zydus Healthcare (USA) LLC without Prejudice and Amending Caption to Reflect Same. Party Zydus Healthcare (USA) LLC terminated. Signed by Judge Maryellen Noreika on 11/3/2022. This order has been emailed to local counsel. (dlw) (Entered: 11/03/2022) (0) |
| Nov 2, 2022 | 9 | WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 10/27/2022, answer due 12/27/2022. (Balick, Steven) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 10 | WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Healthcare (USA) LLC waiver sent on 10/27/2022, answer due 12/27/2022. (Balick, Steven) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 11 | WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Worldwide DMCC waiver sent on 10/27/2022, answer due 1/25/2023. (Balick, Steven) (Entered: 11/02/2022) (1) |
| Nov 2, 2022 | 12 | WAIVER OF SERVICE returned executed by Neurocrine Biosciences, Inc.: For Zydus Lifesciences Limited waiver sent on 10/27/2022, answer due 1/25/2023. (Balick, Steven) (Entered: 11/02/2022) (1) |
| Oct 19, 2022 | 8 | ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 10/24/2022 teleconference is RESET for 11/3/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/19/2022. (dlw) (Entered: 10/19/2022) (0) |
| Oct 14, 2022 | 7 | NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-41) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/14/2022) (4) |
| Oct 6, 2022 | 6 | ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw) (Entered: 10/06/2022) (0) |
| Sep 30, 2022 | 1 | Complaint* (1) |
| Sep 30, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/03/2022) (3) |
| Sep 30, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/18/2022. Date of Expiration of Patent: 09/18/2038.Thirty Month Stay Deadline: 10/11/2024. (mpb) (Entered: 10/03/2022) (2) |
| Sep 30, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,311,532. (mpb) (Entered: 10/03/2022) (1) |
| Sep 30, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (mpb) (Entered: 10/03/2022) (1) |
